| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |